Oxidative stress, lipid rafts, and macrophage reprogramming

Antioxidants and Redox Signaling

Volumn 9, Issue 9, 2007, Pages 1485-1497

  Cuschieri, Joseph ^a,b   Maier, Ronald V ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD11B ANTIGEN; CD16 ANTIGEN; CD18 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; DECAY ACCELERATING FACTOR; FC RECEPTOR; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOCORTIN 4; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDIZING AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN CDC42; PROTEIN KINASE LYN; PROTEIN MD 2; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

CALCIUM TRANSPORT; COMPLEX FORMATION; CYTOSOL; ENZYME ACTIVATION; HUMAN; IMMUNOREGULATION; INFLAMMATION; LIPID COMPOSITION; LIPID RAFT; MACROPHAGE; MULTIPLE ORGAN FAILURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN TRANSPORT; REVIEW; SECOND MESSENGER; STIMULUS RESPONSE; SYSTEMATIC REVIEW; TISSUE FIXATION;

ANIMALS; CYTOKINES; HUMANS; INFLAMMATION; MACROPHAGES; MEMBRANE MICRODOMAINS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 34547920377     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1670     Document Type: Review

References (132)

1. Abdel Shakor AB, Kwiatkowska K, and Sobota A. Cell surface ceramide generation precedes and controls FcgammaRII clustering and phosphorylation in rafts. J Biol Chem 279: 36778-36787, 2004.
2. Akashi M. Role of infection and bleeding in multiple organ involvement and failure. BJR Suppl 27: 69-74, 2005.
3. Aller MA, Arias JL, and Arias J. Abnormal inflammatory response to trauma: the paradoxical meaning of the ischaemia-reperfusion phenomenon. Injury 35: 835-836; author reply 836-837, 2004.
4. Aronis A, Madar Z, and Tirosh O. Mechanism underlying oxidative stress-mediated lipotoxicity: exposure of J774.2 macrophages to triacylglycerols facilitates mitochondrial reactive oxygen species production and cellular necrosis. Free Radic Biol Med 38: 1221-1230, 2005.
5. Benting J, Rietveld A, Ansorge I, and Simons K. Acyl and alkyl chain length of GPI-anchors is critical for raft association in vitro. FEBS Lett 462: 47-50, 1999.
6. Beutler B and Poltorak A. Positional cloning of Lps, and the general role of toll-like receptors in the innate immune response. Eur Cytokine Netw 11: 143-152, 2000.
7. Bhatia M and Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202: 145-156, 2004.
8. Brown DA and London E. Structure and origin of ordered lipid domains in biological membranes. J Membr Biol 164: 103-114, 1998.
9. Bulger EM, Garcia I, and Maier RV. Dithiocarbamates enhance tumor necrosis factor-alpha production by rabbit alveolar macrophages, despite inhibition of NF-kappaB. Shock 9: 397-405, 1998.
10. Bulger EM, Garcia I, and Maier RV. Intracellular antioxidant activity is necessary to modulate the macrophage response to endotoxin. Shock 18: 58-63, 2002.
11. Bulger EM and Maier RV. An argument for Vitamin E supplementation in the management of systemic inflammatory response syndrome. Shock 19: 99-103, 2003.
12. Cao LC, Honeyman T, Jonassen J, and Scheid C. Oxalate-induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells. Kidney Int 57: 2403-2411, 2000.
13. Carter AB, Monick MM, and Hunninghake GW. Lipopolysaccharide-induced NF-kappaB activation and cytokine release in human alveolar macrophages is PKC-independent and TK- and PC-PLC-dependent. Am J Respir Cell Mol Biol 18: 384-391, 1998.
14. Chamberlain LH. Detergents as tools for the purification and classification of lipid rafts. FEBS Lett 559: 1-5, 2004.
15. Cheadle WG and Turina M. Infection and organ failure in the surgical patient: a tribute to seminal contributions by Hiram C. Polk, Jr, M.D. Am J Surg 190: 173-177, 2005.
16. Cuschieri J. Implications of lipid raft disintegration: enhanced anti-inflammatory macrophage phenotype. Surgery 136: 169-175, 2004.
17. Cuschieri J, Billgren J, and Maier RV. Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: A condition reversed by PKC activation. J Leukoc Biol 80: 1289-1297, 2006.
18. Cuschieri J, Billgren J, and Maier RV. Phosphatidylcholine-specific phospholipase C (PC-PLC) is required for LPS-mediated macrophage activation through CD14. J Leukoc Biol 80: 407-414, 2006.
19. Cuschieri J, Bulger E, Biligren J, Garcia I, and Maier RV. Vitamin e inhibits endotoxin-mediated transport of phosphatases to lipid rafts. Shock 27:19-24, 2007.
20. Cuschieri J, Bulger E, Billgren J, Garcia I, and Maier RV. Acid sphingomylinase is required for lipid raft TLR4 complex formation. Surg Infect 8: 91-106, 2007.
21. Cuschieri J, Bulger E, Garcia I, Jelacic S, and Maier RV. Calcium/calmodulin-dependent kinase II is required for platelet-activating factor priming. Shock 23: 99-106, 2005.
22. Cuschieri J, Bulger E, Garcia I, and Maier RV. Oxidative-induced calcium mobilization is dependent on annexin VI release from lipid rafts. Surgery 138: 158-164, 2005.
23. Cuschieri J, Bulmus V, Gourlay D, Garcia I, Hoffman A, Stayton P, and Maier RV. Modulation of macrophage responsiveness to lipopolysaccharide by IRAK-1 manipulation. Shock 21: 182-188, 2004.
24. de Diego I, Schwartz F, Siegfried H, Dauterstedt P, Heeren J, Beisiegel U, Enrich C, and Grewal T. Cholesterol modulates the membrane binding and intracellular distribution of annexin 6. J Biol Chem 277: 32187-32194, 2002.
25. Diks SH, Richel DJ, and Peppelenbosch MP. LPS signal transduction: the picture is becoming more complex. Curr Top Med Chem 4: 1115-1126, 2004.
26. Dong W, Simeonova PP, Gallucci R, Matheson J, Fannin R, Montuschi P, Flood L, and Luster MI. Cytokine expression in hepatocytes: role of oxidant stress. J Interferon Cytokine Res 18: 629-638, 1998.
27. Duncan RF, Peterson H, Hagedorn CH, and Sevanian A. Oxidative stress increases eukaryotic initiation factor 4E phosphorylation in vascular cells. Biochem J 369: 213-225, 2003.
28. Fan J, Kapus A, Li YH, Rizoli S, Marshall JC, and Rotstein OD. Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. Am J Respir Cell Mol Biol 22: 412-421, 2000.
29. Fan J, Marshall JC, Jimenez M, Shek PN, Zagorski J, and Rotstein OD. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J Immunol 161: 440-447, 1998.
30. Fang H, Pengal RA, Cao X, Ganesan LP, Wewers MD, Marsh CB, and Tridandapani S. Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J Immunol 173: 360-366, 2004.
31. Ferrandon D, Jung AC, Criqui M, Lemaitre B, Uttenweiler-Joseph S, Michaut L, Reichhart J, and Hoffmann JA. A drosomycin-GFP reporter transgene reveals a local immune response in Drosophila that is not dependent on the Toll pathway. EMBO J 17: 1217-1227, 1998.
32. Finberg RW, Re F, Popova L, Golenbock DT, and Kurt-Jones EA. Cell activation by Toll-like receptors: role of LBP and CD14. J Endotoxin Res 10: 413-418, 2004.
33. Fingerle-Rowson G, Auers J, Kreuzer E, Fraunberger P, Blumenstein M, and Ziegler-Heitbrock LH. Expansion of CD14+CD16+ monocytes in critically ill cardiac surgery patients. Inflammation 22: 367-379, 1998.
34. Gallay P, Jongeneel CV, Barras C, Burnier M, Baumgartner JD, Glauser MP, and Heumann D. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes. J Immunol 150: 5086-5093, 1993.
35. Gaus K, Rodriguez M, Ruberu KR, Gelissen I, Sloane TM, Kritharides L, and Jessup W. Domain-specific lipid distribution in macrophage plasma membranes. J Lipid Res 46: 1526-1538, 2005.
36. Gegner JA, Ulevitch RJ, and Tobias PS. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 270: 5320-5325, 1995.
37. Giannoudis PV. Current concepts of the inflammatory response after major trauma: an update. Injury 34: 397-404, 2003.
38. Giniatullin AR, Darios F, Shakirzyanova A, Davletov B, and Giniatullin R. SNAP25 is a pre-synaptic target for the depressant action of reactive oxygen species on transmitter release. J Neurochem 98: 1789-1797, 2006.
39. Goldkorn T, Balaban N, Shannon M, Chea V, Matsukuma K, Gilchrist D, Wang H, and Chan C. H2O2 acts on cellular membranes to generate ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells. J Cell Sci 111: 3209-3220, 1998.
40. Gomez-Munoz A, Kong JY, Salh B, and Steinbrecher UP. Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages. J Lipid Res 45: 99-105, 2004.
41. Grassme H, Gulbins E, Brenner B, Ferlinz K, Sandhoff K, Harzer K, Lang F, and Meyer TF. Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell 91: 605-615, 1997.
42. Grove RI, Allegretto NJ, Kiener PA, and Warr GA. Lipopolysaccharide (LPS) alters phosphatidylcholine metabolism in elicited peritoneal macrophages. J Leukoc Biol 48: 38-42, 1990.
43. Guha M and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94, 2001.
44. Gulbins E and Kolesnick R. Raft ceramide in molecular medicine. Oncogene 22: 7070-7077, 2003.
45. Ha H, Kwak HB, Lee SK, Na DS, Rudd CE, Lee ZH, and Kim HH. Membrane rafts play a crucial role in receptor activator of nuclear factor kappaB signaling and osteoclast function. J Biol Chem 278: 18573-18580, 2003.
46. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL, and Goyert SM. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4: 407-414, 1996.
47. Higgins CF and Gottesman MM. Is the multidrug transporter a flippase? Trends Biochem Sci 17: 18-21, 1992.
48. Hotchkiss RS, Bowling WM, Karl IE, Osborne DF, and Flye MW. Calcium antagonists inhibit oxidative burst and nitrite formation in lipopolysaccharide-stimulated rat peritoneal macrophages. Shock 8: 170-178, 1997.
49. Hoyal CR, Gozal E, Zhou H, Foldenauer K, and Forman HJ. Modulation of the rat alveolar macrophage respiratory burst by hydroperoxides is calcium dependent. Arch Biochem Biophys 326: 166-171, 1996.
50. Hoyal CR, Thomas AP, and Forman HJ. Hydroperoxide-induced increases in intracellular calcium due to annexin VI translocation and inactivation of plasma membrane Ca2+-ATPase. J Biol Chem 271: 29205-29210, 1996.
51. Hu J, Jacinto R, McCall C, and Li L. Regulation of IL-1 receptor-associated kinases by lipopolysaccharide. J Immunol 168: 3910-3914, 2002.
52. Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, and Makino H. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 50: 1457-1467, 2004.
53. Jones BW, Heldwein KA, Means TK, Saukkonen JJ, and Fenton MJ. Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann Rheum Dis 60 Suppl 3: iii6-12, 2001.
54. Kampalath B, Cleveland RP, Chang CC, and Kass L. Monocytes with altered phenotypes in posttrauma patients. Arch Pathol Lab Med 127: 1580-1585, 2003.
55. Kannan R, Jin M, Gamulescu MA, and Hinton DR. Ceramide-induced apoptosis: role of catalase and hepatocyte growth factor. Free Radic Biol Med 37: 166-175, 2004.
56. Kasahara K, Watanabe K, Kozutsumi Y, Oohira A, Yamamoto T, and Sanai Y. Association of GPI-anchored protein TAG-1 with src-family kinase Lyn in lipid rafts of cerebellar granule cells. Neurochem Res 27: 823-829, 2002.
57. Kasahara K, Watanabe K, Takeuchi K, Kaneko H, Oohira A, Yamamoto T, and Sanai Y. Involvement of gangliosides in glycosylphosphatidylinositol-anchored neuronal cell adhesion molecule TAG-1 signaling in lipid rafts. J Biol Chem 275: 34701-34709, 2000.
58. Keel M and Trentz O. Pathophysiology of polytrauma. Injury 36: 691-709, 2005.
59. Khadaroo RG, He R, Parodo J, Powers KA, Marshall JC, Kapus A, and Rotstein OD. The role of the Src family of tyrosine kinases after oxidant-induced lung injury in vivo. Surgery 136: 483-488, 2004.
60. Khadaroo RG, Kapus A, Powers KA, Cybulsky MI, Marshall JC, and Rotstein OD. Oxidative stress reprograms lipopolysaccharide signaling via Src kinase-dependent pathway in RAW 264.7 macrophage cell line. J Biol Chem 278: 47834-47841, 2003.
61. Kitchens RL and Munford RS. CD14-dependent internalization of bacterial lipopolysaccharide (LPS) is strongly influenced by LPS aggregation but not by cellular responses to LPS. J Immunol 160: 1920-1928, 1998.
62. Knapp S, de Vos AF, Florquin S, Golenbock DT, and van der Poll T. Lipopolysaccharide binding protein is an essential component of the innate immune response to Escherichia coli peritonitis in mice. Infect Immun 71: 6747-6753, 2003.
63. Kolesnick R. Signal transduction through the sphingomyelin pathway. Mol Chem Neuropathol 21: 287-297, 1994.
64. Kono H, Suzuki T, Yamamoto K, Okada M, Yamamoto T, and Honda Z. Spatial raft coalescence represents an initial step in Fc gamma R signaling. J Immunol 169: 193-203, 2002.
65. Kusumi A, Koyama-Honda I, and Suzuki K. Molecular dynamics and interactions for creation of stimulation-induced stabilized rafts from small unstable steady-state rafts. Traffic 5: 213-230, 2004.
66. Lakhani SA and Bogue CW. Toll-like receptor signaling in sepsis. Curr Opin Pediatr 15: 278-282, 2003.
67. Lee JD, Kato K, Tobias PS, Kirkland TN, and Ulevitch RJ. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J Exp Med 175: 1697-1705, 1992.
68. Lemaitre B. The road to Toll. Nat Rev Immunol. 4: 521-527, 2004.
69. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, and Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86: 973-983, 1996.
70. Levade T and Jaffrezou JP. Signalling sphingomyelinases: which, where, how and why? Biochim Biophys Acta 1438: 1-17, 1999.
71. Leventhal AR, Chen W, Tall AR, and Tabas I. Acid sphingomyelinase- deficient macrophages have defective cholesterol trafficking and efflux. J Biol Chem 276: 4976-4983, 2001.
72. Li Z, Agellon LB, and Vance DE. Phosphatidylcholine homeostasis and liver failure. J Biol Chem 280: 37798-37802, 2005.
73. Malorni W, Testa U, Rainaldi G, Tritarelli E, and Peschle C. Oxidative stress leads to a rapid alteration of transferrin receptor intravesicular trafficking. Exp Cell Res 241: 102-116, 1998.
74. Mannick JA, Rodrick ML, and Lederer JA. The immunologic response to injury. J Am Coll Surg 193: 237-244, 2001.
75. Matsuda D, Nakayama Y, Horimoto S, Kuga T, Ikeda K, Kasahara K, and Yamaguchi N. Involvement of Golgi-associated Lyn tyrosine kinase in the translocation of annexin II to the endoplasmic reticulum under oxidative stress. Exp Cell Res 312: 1205-1217, 2006.
76. Maytin M, Leopold J, and Loscalzo J. Oxidant stress in the vasculature. Curr Atheroscler Rep 1: 156-164, 1999.
77. Melkonian KA, Ostermeyer AG, Chen JZ, Roth MG, and Brown DA. Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J Biol Chem 274: 3910-3917, 1999.
78. Monick MM, Mallampalli RK, Carter AB, Flaherty DM, McCoy D, Robeff PK, Peterson MW, and Hunninghake GW. Ceramide regulates lipopolysaccharide-induced phosphatidylinositol 3-kinase and Akt activity in human alveolar macrophages. J Immunol 167: 5977-5985, 2001.
79. Moore FA and Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 75: 257-277, 1995.
80. Moore FA, Moore EE, Poggetti RS, and Read RA. Postinjury shock and early bacteremia. A lethal combination. Arch Surg 127: 893-897; discussion 897-898, 1992.
81. Murphy JK, Hoyal CR, Livingston FR, and Forman HJ. Modulation of the alveolar macrophage respiratory burst by hydroperoxides. Free Radic Biol Med 18: 37-45, 1995.
82. Nardini M, Leonardi F, Scaccini C, and Virgili F. Modulation of ceramide-induced NF-kappaB binding activity and apoptotic response by caffeic acid in U937 cells: comparison with other antioxidants. Free Radic Biol Med 30: 722-733, 2001.
83. Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, Radella F, Garcia I, and Maier RV. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 236: 814-822, 2002.
84. Nurminen TA, Holopainen JM, Zhao H, and Kinnunen PK. Observation of topical catalysis by sphingomyelinase coupled to microspheres. J Am Chem Soc 124: 12129-12134, 2002.
85. Olsson S and Sundler R. The role of lipid rafts in LPS-induced signaling in a macrophage cell line. Mol Immunol 43: 607-612, 2006.
86. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, and Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97: 13766-13771, 2000.
87. Pallister I. Current concepts of the inflammatory response after major trauma: an update. Injury 36: 227-229; author reply 229-230, 2005.
88. Pena LA, Fuks Z, and Kolesnick R. Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol 53: 615-621, 1997.
89. Penkowa M, Espejo C, Martinez-Caceres EM, Poulsen CB, Montalban X, and Hidalgo J. Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis. J Neuroimmunol 119: 248-260, 2001.
90. Pielsticker LK, Mann KJ, Lin WL, and Sevlever D. Raft-like membrane domains contain enzymatic activities involved in the synthesis of mammalian glycosylphosphatidylinositol anchor intermediates. Biochem Biophys Res Commun 330: 163-171, 2005.
91. Pinsky MR. Dysregulation of the immune response in severe sepsis. Am J Med Sci 328: 220-229, 2004.
92. Pollet S, Bottex-Gauthier C, Li M, Potier P, Favier A, and Vidal D. Insight into some of the signaling pathways triggered by a lipid immunomodulator. Immunopharmacol Immunotoxicol 24: 527-546, 2002.
93. Powers KA, Szaszi K, Khadaroo RG, Tawadros PS, Marshall JC, Kapus A, and Rotstein OD. Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J Exp Med 203: 1951-1061, 2006.
94. Pulliam L, Sun B, and Rempel H. Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J Neuroimmunol 157: 93-98, 2004.
95. Quilty MC, King AE, Gai WP, Pountney DL, West AK, Vickers JC, and Dickson TC. Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection. Exp Neurol 199: 249-256, 2006.
96. Radeva G, Perabo J, and Sharom FJ. P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains. FEBS J 272: 4924-4937, 2005.
97. Ramirez R, Carracedo J, Berdud I, Carretero D, Merino A, Rodriguez M, Tetta C, Martin-Malo A, and Aljama P. Microinflammation in hemodialysis is related to a preactivated subset of monocytes. Hemodial Int 10 Suppl 1: S24-27, 2006.
98. Reddy RC, Chen GH, Tekchandani PK, and Standiford TJ. Sepsis-induced immunosuppression: from bad to worse. Immunol Res 24: 273-287, 2001.
99. Ricciarelli R, Tasinato A, Clement S, Ozer NK, Boscoboinik D, and Azzi A. alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem J 334: 243-249, 1998.
100. Richter C. Oxidative stress, mitochondria, and apoptosis. Restor Neurol Neurosci 12: 59-62, 1998.
101. Saadia R and Schein M. Multiple organ failure. How valid is the "two hit" model? J Accid Emerg Med 16: 163-166; discussion 166-167, 1999.
102. Sands WA, Clark JS, and Liew FY. The role of a phosphatidylcholine- specific phospholipase C in the production of diacylglycerol for nitric oxide synthesis in macrophages activated by IFN-gamma and LPS. Biochem Biophys Res Commun 199: 461-466, 1994.
103. Santanam N, Murphy AA, and Parthasarathy S. Macrophages, oxidation, and endometriosis. Ann NY Acad Sci 955: 183-198; discussion 199-200, 396-406, 2002.
104. Sauaia A, Moore FA, Moore EE, and Lezotte DC. Early risk factors for postinjury multiple organ failure. World J Surg 20: 392-400, 1996.
105. Scherberich JE. Proinflammatory blood monocytes: main effector and target cells in systemic and renal disease; background and therapeutic implications. Int J Clin Pharmacol Ther 41:459-464, 2003.
106. Schramm AB, Brandenburg K, Rietschel ET, Flad HD, Carroll SF, and Seydel U. Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes. FEBS Lett 399: 267-271, 1996.
107. Schutt C. Cd14. Int J Biochem Cell Biol 31: 545-549, 1999.
108. Sester U, Sester M, Heine G, Kaul H, Girndt M, and Kohler H. Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment. Nephrol Dial Transplant 16: 1402-1408, 2001.
109. Simons K and Ikonen E. Functional rafts in cell membranes. Nature 387: 569-572, 1997.
110. Skinner NA, MacIsaac CM, Hamilton JA, and Visvanathan K. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens. Clin Exp Immunol 141: 270-278, 2005.
111. Smets LA, Van Rooij H, and Salomons GS. Signalling steps in apoptosis by ether lipids. Apoptosis 4: 419-427, 1999.
112. Stein D, Roth S, Vogelsang E, and Nusslein-Volhard C. The polarity of the dorsoventral axis in the Drosophila embryo is defined by an extracellular signal. Cell 65: 725-735, 1991.
113. Steinbrecher UP, Gomez-Munoz A, and Duronio V. Acid sphingomyelinase in macrophage apoptosis. Curr Opin Lipidol 15: 531-537, 2004.
114. Szaflarska A, Baj-Krzyworzeka M, Siedlar M, Weglarczyk K, Ruggiero I, Hajto B, and Zembala M. Antitumor response of CD14+/CD16+ monocyte subpopulation. Exp Hematol 32: 748-755, 2004.
115. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, and Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443-451, 1999.
116. Testi R. Sphingomyelin breakdown and cell fate. Trends Biochem Sci 21: 468-471, 1996.
117. Traber MG and Packer L. Vitamin E: beyond antioxidant function. Am J Clin Nutr 62: 1501S-1509S, 1995.
118. Triantafilou M, Brandenburg K, Kusumoto S, Fukase K, Mackie A, Seydel U, and Triantafilou K. Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses. Biochem J 381: 527-536, 2004.
119. Triantafilou M, Miyake K, Golenbock DT, and Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 115: 2603-2611, 2002.
120. Tschaikowsky K, Schmidt J, and Meisner M. Modulation of mouse endotoxin shock by inhibition of phosphatidylcholine-specific phospholipase C. J Pharmacol Exp Ther 285: 800-804, 1998.
121. Ueda N, Camargo SM, Hong X, Basnakian AG, Walker PD, and Shah SV. Role of ceramide synthase in oxidant injury to renal tubular epithelial cells. J Am Soc Nephrol 12: 2384-2391, 2001.
122. Utermohlen O, Karow U, Lohler J, and Kronke M. Severe impairment in early host defense against Listeria monocytogenes in mice deficient in acid sphingomyelinase. J Immunol 170: 2621-2628, 2003.
123. Ward PA. Immunosuppression after trauma. Crit Care Med 33: 1453-1454, 2005.
124. Weigand MA, Horner C, Bardenheuer HJ, and Bouchon A. The systemic inflammatory response syndrome. Best Pract Res Clin Anaestheslol 18: 455-475, 2004.
125. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, and Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433, 1990.
126. Xiao YQ, Freire-de-Lima CG, Janssen WJ, Morimoto K, Lyu D, Bratton DL, and Henson PM. Oxidants selectively reverse TGF-beta suppression of proinflammatory mediator production. J Immunol 176: 1209-1217, 2006.
127. Yamamoto M and Akirz S, TIR domain-containing adaptors regulate TLR signaling pathways. Adv Exp Med Biol 560: 1-9, 2005.
128. Young RM, Holowka D, and Baird B. A lipid raft environment enhances Lyn kinase activity by protecting the active site tyrosine from dephosphorylation. J Biol Chem 278: 20746-20752, 2003.
129. Zager RA, Burkhart KM, and Johnson A. Sphingomyelinase and membrane sphingomyelin content: determinants of proximal tubule cell susceptibility to injury. J Am Soc Nephrol 11: 894-902, 2000.
130. Zhang F, Zhao G, and Dong Z. Phosphatidylcholine-specific phospholipase C and D in stimulation of RAW264.7 mouse macrophage-like cells by lipopolysaccharide. Int Immunopharmacol 1: 1375-1384, 2001.
131. Ziegler-Heitbrock HW, Strobel M, Fingerle G, Schlunck T, Pforte A, Blumenstein M, and Haas JG. Small (CD14+/CD16+) monocytes and regular monocytes in human blood. Pathobiology 59: 127-130, 1991.
132. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 81: 584-592, 2007.